SH3YL1: A Potential Drug Target and Biomarker (G26751)

Target Name: SH3YL1

NCBI ID: G26751

SH3YL1

SH3YL1: A Potential Drug Target and Biomarker

SH3YL1, also known as FLJ39121, is a protein that is expressed in various tissues and cell types in the human body. Its function and significance in the cell have not yet been fully understood, but research has shown that it plays a critical role in several cellular processes, including cell signaling, DNA replication, and metabolism. As a result, SH3YL1 has potential as a drug target or biomarker.

SH3YL1 is a member of the SH3 domain family, which is known for its role in protein-protein interactions and client-protein interactions. This family of proteins has been implicated in various cellular processes, including cell signaling, DNA replication, and metabolism. The SH3YL1 protein is known to play a critical role in the regulation of DNA replication, specifically in the initiation complex of DNA replication.

SH3YL1 has been shown to be involved in the regulation of DNA replication initiation. During DNA replication, the protein is involved in the formation of the initiation complex, which is the first step in the replication process. The initiation complex consists of several proteins, including the double-stranded DNA, the template, the primers, and the enzymes responsible for the formation of the double-stranded DNA.

Research has shown that SH3YL1 plays a critical role in the regulation of the initiation complex. Studies have shown that SH3YL1 is able to interact with the protein SSB, which is responsible for the regulation of DNA replication initiation. This interaction between SH3YL1 and SSB suggests that SH3YL1 may be a potential drug target or biomarker that can be targeted by small molecules or other therapeutic agents.

In addition to its role in DNA replication, SH3YL1 has also been shown to be involved in the regulation of cell signaling. The SH3YL1 protein has been shown to play a role in the regulation of several cellular signaling pathways, including the T-cell signaling pathway and the NF-kappa-B signaling pathway. These signaling pathways are important for the regulation of various cellular processes, including cell growth, differentiation, and inflammation.

The T-cell signaling pathway is a critical pathway that regulates the development and function of T-cells, which are a type of immune cell that play a critical role in the regulation of the immune system. The T-cell signaling pathway is involved in the regulation of cell growth, differentiation, and survival, and is regulated by a variety of signaling molecules, including T-cell factor (TGF-β), which is a critical cytokine that regulates the T-cell signaling pathway.

The NF-kappa-B signaling pathway is a critical pathway that regulates inflammation and cellular signaling. The NF-kappa-B signaling pathway is involved in the regulation of various cellular processes, including inflammation, cell growth, and survival. The NF-kappa-B signaling pathway is regulated by a variety of signaling molecules, including nuclear factor kappa B (NF-kappa-B), which is a critical transcription factor that regulates the NF-kappa-B signaling pathway.

In conclusion, SH3YL1 is a protein that is involved in several critical cellular processes, including cell signaling, DNA replication, and metabolism. Its role in these processes makes it a potential drug target or biomarker. Further research is needed to fully understand the function and significance of SH3YL1, but its potential as a drug target or biomarker is an exciting area of research that could have significant implications for the development of new therapeutic agents.

Protein Name: SH3 And SYLF Domain Containing 1

The "SH3YL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SH3YL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets